SCHEMBL1895578

SCHEMBL1895578

COc1ccc(NC(=O)CSc2nc3ccccc3c(=O)n2Cc2ccco2)c(OC)c1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.75
▸ HTT P42858 1/20 0.75
▸ KMT2A Q03164 6/20 0.73
▸ MEN1 O00255 5/20 0.73
▸ ALDH1A1 P00352 5/20 0.70
▸ LMNA P02545 3/20 0.68
▸ NPY1R P25929 1/20 0.66
▸ NPY2R P49146 1/20 0.66
▸ TP53 P04637 1/20 0.65
▸ THRB P10828 1/20 0.65
▸ RAB9A P51151 1/20 0.65
▸ USP2 O75604 2/20 0.64
▸ TSHR P16473 2/20 0.64
▸ TDP1 Q9NUW8 2/20 0.64
▸ KDM4E B2RXH2 2/20 0.64
▸ POLB P06746 1/20 0.64
▸ PKM P14618 1/20 0.64
▸ ALOX15 P16050 2/20 0.63
▸ HPGD P15428 2/20 0.63
▸ ESR1 P03372 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30774061 1.00 L3MBTL1 (0.75) L3MBTL1HTTKMT2AMEN1ALDH1A1
SCHEMBL12668678 0.85 MAPT (0.57) L3MBTL1HTTKMT2AMEN1ALDH1A1
SCHEMBL25482016 0.80 LMNA (0.82) L3MBTL1HTTKMT2AMEN1ALDH1A1
SCHEMBL12285666 0.78 RXFP1 (0.73) KMT2AMEN1ALDH1A1LMNATP53
SCHEMBL25481992 0.76 SMN1; SMN2 (0.77) L3MBTL1KMT2AMEN1ALDH1A1LMNA
SCHEMBL18559224 0.76 USP2 (1.00) L3MBTL1KMT2AMEN1ALDH1A1LMNA
SCHEMBL12288669 0.75 KMT2A (0.57) HTTKMT2AMEN1ALDH1A1LMNA
SCHEMBL470775 0.74 MAPT (0.85) KMT2AMEN1ALDH1A1TP53THRB
SCHEMBL25481977 0.73 SMN1; SMN2 (0.67) L3MBTL1KMT2AMEN1ALDH1A1LMNA
SCHEMBL12285491 0.72 RXFP1 (1.00) TP53THRBTDP1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9504676-B2 Molecules inhibiting a metabolic pathway involving the Syk protein tyrosine kinase and method for identifying said molecules CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2016-11-29 — — US disclosed
US-9504676-B2 Molecules inhibiting a metabolic pathway involving the Syk protein tyrosine kinase and method for identifying said molecules CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2016-11-29 — — US disclosed
US-20140179679-A1 MOLECULES INHIBITING A METABOLIC PATHWAY INVOLVING THE SYK PROTEIN TYROSINE KINASE AND METHOD FOR IDENTIFYING SAID MOLECULES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2014-06-26 — — US disclosed
US-20140179679-A1 MOLECULES INHIBITING A METABOLIC PATHWAY INVOLVING THE SYK PROTEIN TYROSINE KINASE AND METHOD FOR IDENTIFYING SAID MOLECULES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2014-06-26 — — US disclosed
US-20110112098-A1 MOLECULES INHIBITING A METABOLIC PATHWAY INVOLVING THE SYK PROTEIN TYROSINE KINASE AND METHOD FOR IDENTIFYING SAID MOLECULES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2011-05-12 — — US disclosed
US-20110112098-A1 MOLECULES INHIBITING A METABOLIC PATHWAY INVOLVING THE SYK PROTEIN TYROSINE KINASE AND METHOD FOR IDENTIFYING SAID MOLECULES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2011-05-12 — — US disclosed
US-20110112098-A1 MOLECULES INHIBITING A METABOLIC PATHWAY INVOLVING THE SYK PROTEIN TYROSINE KINASE AND METHOD FOR IDENTIFYING SAID MOLECULES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2011-05-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140179679-A1 MOLECULES INHIBITING A METABOLIC PATHWAY INVOLVING THE SYK PROTEIN TYROSINE KINASE AND METHOD FOR IDENTIFYING SAID MOLECULES SYK, BTK, TYRO3 L3MBTL1 2505/4885HTT 4431/4885KMT2A 1901/4885
US-20110112098-A1 MOLECULES INHIBITING A METABOLIC PATHWAY INVOLVING THE SYK PROTEIN TYROSINE KINASE AND METHOD FOR IDENTIFYING SAID MOLECULES SYK, BTK, TYRO3 L3MBTL1 2505/4885HTT 4431/4885KMT2A 1901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback